Plasma kinetics of zeaxanthin and 3′-dehydro-lutein after multiple oral doses of synthetic zeaxanthin

American Journal of Clinical Nutrition

Volumn 79, Issue 3, 2004, Pages 410-417

  Hartmann, Dieter ^a   Thürmann, Petra A ^b   Spitzer, Volker ^a   Schalch, Wolfgang ^a   Manner, Birke ^b   Cohn, William ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

Author keywords

all E 3 dehydro lutein; Beadlet formulation; Carotenoids; Lutein; Multiple oral dose kinetics; Xanthophyll; Zeaxanthin

Indexed keywords

3' DEHYDROLUTEIN; CAROTENOID; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN; BETA CAROTENE; DRUG DERIVATIVE;

ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MONITORING; DRUG TOLERABILITY; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PLASMA; STEADY STATE; TIME; VOLUNTEER; ADULT; BIOAVAILABILITY; BLOOD; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET SUPPLEMENTATION; FEMALE; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; RETINA MACULA DEGENERATION; RISK FACTOR;

ADMINISTRATION, ORAL; ADULT; BETA CAROTENE; BIOLOGICAL AVAILABILITY; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LUTEIN; MACULAR DEGENERATION; MALE; RISK FACTORS; XANTHOPHYLLS;

EID: 23644436300     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/79.3.410     Document Type: Article

References (25)

1. Schalch W. Carotenoids in the retina - a review of their possible role in preventing or limiting damage caused by light and oxygen. In: Emerit I, Chance B, eds. Free radicals and aging, Basel, Switzerland: Birkhäuser Verlag, 1992:280-98.
2. Schalch W, Dayhaw-Barker P, Barker FM. The carotenoids in the human macula. In: Taylor A, ed. Nutritional and environmental influences on the eye. Boca Raton, FL: CRC Press, 1999:215-50.
3. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. In: Sies H, ed. Advances in pharmacology. Vol 38. London: Academic Press, 1996: 537-56.
4. EDCC (Eye Disease Case-Control) Study Group. Antioxidant status and neovascular age-related macular degeneration. Arch Ophthalmol 1993;111:104-9.
5. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C and E and advanced age-related macular degeneration. JAMA 1994;27:1413-20.
6. Chug-Ahuja JK, Holden JM, Forman MR, Mangels AR, Beecher GR, Lanza E. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc 1993;93:318-23.
7. Hart DJ, Scott KJ. Development and evaluation of an HPLC method for the analysis of carotenoids in foods, and the measurement of the carotenoid content of vegetables and fruits commonly consumed in the UK. Food Chem 1995;54:101-11.
8. Sommerburg OG, Siems WG, Hurst JS, Lewis JW, Kliger DS, van Kuijk FJGM. Lutein and zeaxanthin are associated with photoreceptors in the human retina. Curr Eye Res 1999;19:491-5.
9. Nebeling LC, Forman MR, Graubard BI, Snyder RA. Changes in carotenoid intake in the United States: the 1987 and 1992 National Health Interview Surveys. J Am Diet Assoc 1997;97:991-6.
10. Le Marchand L, Hankin JH, Bach F, et al. An ecological study of diet and lung cancer in the South Pacific. Int J Cancer 1995;63:18-23.
11. Mohamedshah F, Douglas JS, Amann MM, Heimbach JM. Dietary intakes of lutein + zeaxanthin and total carotenoids among Americans age 50 and above. FASEB J 1999;13:A554(abstr).
12. Burri JJ, Neidlinger TR, Clifford AJ. Serum carotenoid depletion follows first order kinetics in healthy women fed naturally low carotenoid diets. J Nutr 2001;131:2096-100.
13. Bowen PE, Herbst-Espinosa SM, Husaain EA, Stacewicz-Sapuntzakis M. Esterification does not impair lutein bioavailability in humans. J Nutr 2002;132:3668-73.
14. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr 2003;133:992-8.
15. Aebischer CP, Schierle J, Schüep W. Simultaneous determination of retinol, tocopherols, carotene, lycopene, and xanthophylls in plasma by means of reversed-phase high-performance liquid chromatography. Methods Enzymol 1999;299:348-62.
16. Richmond W. Preparation and properties of a cholesterol oxidase from Nocardla sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 1973;19:1350-6.
17. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-80.
18. McGowan MW, Artiss JD, Strandbergh DR, Zak B. A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 1983;29:538-42.
19. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York: Marcel Dekker, Inc, 1982.
20. Schulz HU, Steinijeans VW. Striving for standards in bioequivalence assessment: a review. Int J Clin Pharmacol Ther Toxicol 1992;30 (suppl):S1-6.
21. Dimitrov NV, Meyer C, Ullrey D, et al. Bioavailability of beta-carotene in humans. Am J Clin Nutr 1988;48:298-304.
22. Rock CL, Swendseid ME, Jacob RA, McKee RW. Plasma carotenoid levels in human subjects fed a low carotenoid diet. J Nutr 1992;122:96-100.
23. Boxenbaum H, Battle M. Effective half-life in clinical pharmacology. J Clin Pharmacol 1995;35:763-6.
24. Khachik F, Beecher GR, Goli MB, Lusby WR, Smith JC Jr. Separation and identification of carotenoids and their oxidation products in the extracts of human plasma. Anal Chem 1992;64:2111-22.
25. Schiedt K. Absorption and metabolism of carotenoids in birds, fish and crustaceans. In: Britton G, Liaaen-Jensen S, Pfander H, eds. Carotenoids. Basel, Switzerland: Birkhäuser Verlag, 1998:285-358.